-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on Eli Lilly, Raises Price Target to $1347

Benzinga·07/08/2026 16:45:54
Listen to the news
Morgan Stanley analyst Terence Flynn maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $1344 to $1347.